Related Experiment Video
Updated: May 13, 2025

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Strategies for the Secondary Prevention of Atherosclerotic Cardiovascular Disease
Madelyn Hurwitz1, Olayinka J Agboola2, Abhishek Gami3
1School of Medicine, University of Virginia Charlottesville, VA.
Insights
Patients with atherosclerotic cardiovascular disease (ASCVD) need multifactorial strategies for secondary prevention. This review details interventions for lipid control, inflammation, diabetes, and other factors to reduce cardiovascular events.
Area of Science:
- Cardiology
- Preventive Medicine
Background:
- Patients with atherosclerotic cardiovascular disease (ASCVD) face high risks of morbidity and mortality from recurrent events.
- Secondary prevention requires comprehensive strategies beyond traditional treatments like statins and anti-platelets.
Purpose of the Study:
- To review current interventions for optimizing secondary prevention in ASCVD patients.
- To discuss research and indications for additional therapies targeting risk factors.
Main Methods:
- Literature review of studies on secondary prevention in ASCVD.
- Analysis of interventions for lipid control, inflammation, diabetes, and other risk factors.
- Examination of anti-thrombotic therapies and lifestyle modifications.
Main Results:
- Traditional management includes statins, blood pressure control, and anti-platelets.
- Additional targets for optimization include advanced lipid management, inflammation control, and diabetes management.
- Other key areas include lifestyle optimization, beta-blockers, RAAS inhibitors, vaccinations, and anti-thrombotic strategies.
Conclusions:
- Optimizing secondary prevention in ASCVD necessitates a multifactorial approach.
- Emerging targets and therapies offer improved risk reduction strategies.
- This review provides a comprehensive overview of current evidence-based interventions.
Abstract:
Patients with atherosclerotic cardiovascular disease (ASCVD), such as those with a history of MI or stroke, are at high risk for morbidity and mortality associated with future cardiovascular events. Ideal management of these patients requires a multifactorial strategy for risk factor mitigation and prevention of additional cardiovascular events. Traditional management of secondary prevention patients involves lipid-lowering with statins, blood pressure control, and anti-platelet treatment. Several additional targets have been identified to optimize the secondary prevention of ASCVD, such as further lipid control, inflammation management, lifestyle and weight optimization, strict diabetes control, use of β-blockers, use of renin-angiotensin-aldosterone system inhibitors, vaccinations, and additional considerations of anti-thrombotic therapies. This review will describe the interventions associated with these targets, as well as the relevant research and indications for these therapies.
More Related Videos
Related Concept Videos
Preventive Healthcare Services
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cardiovascular Drugs: Classification based on Therapeutic Indications

